Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 31

Trial Status

Completed3
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05324384Phase 2Unknown
Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
Hemangioendothelioma
PrincipalinvestigatorStart date: 2022-04-05
NCT04775173Phase 2Completed
Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
Kaposiform Hemangioendothelioma
PrincipalinvestigatorStart date: 2021-02-17
NCT03188068Phase 2Completed
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
Kaposiform HemangioendotheliomaKasabach Merritt Phenomenon
PrincipalinvestigatorStart date: 2017-06-01
NCT06763315Phase 2Not Yet Recruiting
Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
Plexiform Neurofibromas (PN)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05324384Phase 2PrincipalInvestigator

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Hemangioendothelioma
Unknown
NCT04775173Phase 2PrincipalInvestigator

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

Kaposiform Hemangioendothelioma
Completed
NCT03188068Phase 2PrincipalInvestigator

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

Kaposiform HemangioendotheliomaKasabach Merritt Phenomenon
Completed
NCT02342275Phase 3PrincipalInvestigator

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma

Hemangioma
Completed
NCT06763315Phase 2PrincipalInvestigator

Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children

Plexiform Neurofibromas (PN)
Not Yet Recruiting

All 5 trials loaded